Drugs / Alphanate SD/HT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00555555 | Sep 2007 → Dec 2028 expected | hereditary von Willebrand disease | Grifols Biologicals, LLC | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alphanate SD/HT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00555555 ↗ |
| Action | Restore | “as replacement therapy” NCT00555555 ↗ |
| Modality | Protein / enzyme biologic | “FVIII/VWF Complex (Human)” NCT00555555 ↗ |